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Introduction: The availability of imaging makers of early placental circulation development is limited.
This study aims to develop a feasible and reliable method to assess preconceptional and early ﬁrst-
trimester utero-placental vascular volumes using three-dimensional power Doppler (3D PD) ultra-
sound on two different Virtual Reality (VR) systems.
Methods: 3D PD ultrasound images of the uterine and placental vasculature were obtained in 35 women,
either preconceptionally (n ¼ 5), or during pregnancy at 7 (n ¼ 10), 9 (n ¼ 10) or 11 (n ¼ 10) weeks of
gestation. Preconceptional uterine vascular volume (UVV), ﬁrst-trimester placental vascular volume
(PVV) and embryonic vascular volume (EVV) were measured by two observers on two VR systems, i.e., a
Barco I-Space and VR desktop. Intra- and inter-observer agreement and intersystem agreement were
assessed by intra-class correlation coefﬁcients (ICC) and absolute and relative differences.
Results: Uterine-, embryonic- and placental vascular volume measurements showed good to excellent
intra- and inter-observer agreement and inter-system reproducibility with most ICC above 0.80 and
relative differences of less than 20% preconceptionally and almost throughout the entire gestational age
range. Inter-observer agreement of PVV at 11 weeks gestation was suboptimal (ICC 0.69, relative dif-
ference 50.1%).
Discussion: Preconceptional and ﬁrst-trimester 3D PD ultrasound utero-placental and embryonic
vascular volume measurements using VR are feasible and reliable. Longitudinal cohort studies with
repeated measurements are needed to further validate this and assess their value as new imaging
markers for placental vascular development and ultimately for the prediction of placenta-related
pregnancy complications.
Crown Copyright © 2017 Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Worldwide, millions of women develop fertility problems or
placenta-related pregnancy complications, such as pregnancy-, Placental vascular volume;
volume.
nd Gynecology, Erasmus MC,
, 3000 CA, Rotterdam, The
teegers-Theunissen).
evier Ltd. This is an open access ainduced hypertension, preeclampsia, fetal growth restriction and
preterm birth every year. These complications not only affect the
outcome of a pregnancy, but some can also impact the health of the
mother and her offspring later in life [1e3].
These problems in reproduction can be due to derangements in
the utero-placental vascularization and originate during the peri-
conception period, i.e., 14 weeks prior to conception until 10 weeks
thereafter [4]. Preconceptional uterine vascularization is involved
in endometrial receptivity, decidual selectivity and subsequent
implantation in combination with complex interactions between
hormones, nutrients, growth factors and endometrial genes [5,6]. Article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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decreased pregnancy rates [7,8].
Human placentation is characterized by the remodeling of the
uterine circulation, in particular of the spiral arteries. Remodeling
optimizes maternal blood distribution through a low-resistance
uterine vascular network and ultimately into the placental inter-
villous chamber [9]. Up to around 9 weeks of gestation, extravillous
trophoblast plugs limit maternal blood entry into these intervillous
chambers. These plugs disintegrate thereafter, resulting in the
onset of the utero-placental circulation [10]. An imbalance in this
delicate phenomenon is hypothesized to be the principal mecha-
nism leading to early pregnancy failure. Similarly, if the uterine
portion of the utero-placental circulation fails to develop, adequate
placental and fetal growth will fail [9].
Doppler ultrasound imaging and maternal serum biomarkers of
placental function such as placental growth factor (PlGF) or
pregnancy-associated plasma protein-A (PAPP-A) have been used
to investigate abnormal placentation [11]. Availability of real-time
imaging markers for assessment of in vivo, early uterine and
placental vascularization and function remains limited. The current
state-of-the-art technology for evaluation of in utero placental
vasculature morphology is three-dimensional power Doppler (3D
PD) ultrasound [12]. So far, 3D vascular volumes can be assessed
using the Virtual Organ Computer-aided AnaLysis (VOCAL) tool to
quantify placental vascularization through calculation of vascular-
ization indices (VI), ﬂow indices (FI) and vascularization-ﬂow
indices (VFI). However, results regarding reproducibility are con-
ﬂicting [12e14]. Variations in ultrasound machine settings and also
distance between the range of interest and ultrasound transducer
inﬂuence VOCAL vascularization indices, by affecting power
Doppler calculations. Furthermore, despite availability of 3D volu-
metric data, measurements are still performed in a two-
dimensional (2D) plane, and consequently the third dimension
that allows for more precise volume measurements is not used. At
the Erasmus MC, we have developed a novel, innovative applica-
tion, called V-Scope, that displays volumetric ultrasound datasets
as holograms, using the Barco I-Space CAVE™-like virtual reality
(VR) system (Barco NV, Belgium) [15,16]. Recently, a VR desktop
system, based on technical principles of the I-Space, was developed
to enable clinical implementation of VR [17]. So far, studies using
VR showed accurate and reproducible embryonic and brain
development measurements in early pregnancy and utero-
placental measurements in the late ﬁrst trimester of pregnancy
[18e21].
The aim of this study is to assess feasibility and reliability of 3D
PD ultrasound in combinationwith two VR systems (I-Space and VR
desktop) to measure preconceptional and ﬁrst-trimester vascular
volumes of the uterus, placenta and embryo.
2. Methods
2.1. Study design
Preconceptional, 5 women undergoing in vitro fertilization (IVF)
or intra-cytoplasmic sperm injection (ICSI) treatment were
recruited from the Department of Reproductive Medicine. Two 3D
PD ultrasound images of the utero-placental vasculature were ob-
tained before ovum pick-up. Further, this study was embedded in
the prospective, tertiary hospital-based Rotterdam periconception
cohort (Predict study) with a focus on the inﬂuence of peri-
conceptional lifestyle and environmental factors on human em-
bryonic and fetal growth and development [22]. In 30 pregnant
Predict study participants, two 3D PD ultrasound utero-placental
vascularization images were obtained in the ﬁrst trimester of
pregnancy, i.e., either at 7 (n ¼ 10), 9 (n¼10) or 11 (n¼10) weeksgestational age (GA). Women at least 18 years of age and prior to
pregnancy or with a singleton pregnancy were eligible for inclu-
sion. GA was calculated from the ﬁrst day of the last menstrual
period (LMP) in spontaneous pregnancies, or from oocyte pick-up
day plus 14 days in IVF/ICSI pregnancies. In pregnancies origi-
nating from cryopreserved embryo transfer it was calculated from
the transfer day plus 17 or 18 days, depending on the number of
days between oocyte pick-up and embryonic cryopreservation. In
regular menstrual cycles, but more than 3 days different from 28
days, we adjusted GA for cycle duration. If the LMPwas unknown or
GA determined by crown-rump length (CRL) differed more than 7
days from the LMP, GAwas based on CRL [22]. Study protocols were
approved by the Erasmus MC medical ethics review board and
written informed consent was obtained from all participants (MEC
2004-227 and METC 2015-494).
2.2. Ultrasound scans
Ultrasound scans were performed by one experienced sonog-
rapher (IR) using a Voluson Expert E8 or E10 system (GE, Zipf,
Austria) ultrasound machine with standard settings (pulse repeti-
tion frequency 0.6 kHz, wall motion ﬁlter ‘low1’, quality ‘high’, gain
adjusted to individual image characteristics), using a 6e12 MHz
transvaginal probe. To minimize artifacts and measurement errors
by movement, participants were asked to hold their breath for
approximately 30 s during image acquisition. As variations in
uterine position require individual adaptions to optimize image
acquisition, two ultrasound volumes were obtained per participant.
The ﬁrst volume was acquired visualizing the uterus in the
midsagittal plane. The second volume was obtained after turning
the ultrasound transducer 90 perpendicular to the ﬁrst position.
All ultrasound examinations were performed according to inter-
national guidelines on safe use of Doppler ultrasound in the ﬁrst
trimester of pregnancy and as such, total scanning time was kept as
low as possible (ALARA-principle) and always <30 min to avoid
unnecessary exposure [23e25]. The settings during 3D PD ultra-
sound use resulted in average power levels (i.e. thermal index <0.7)
theoretically allowing for unlimited scanning time. However, 3D PD
ultrasound use was limited to averagely 1 minute (two times a
volume acquisition of 30 seconds).
2.3. Virtual reality technique
In the Barco I-Space, a CAVE™-like VR environment, using the V-
Scope volume rendering application, 3D ultrasound volumes can be
visualized as true 3D “holograms” [16]. Additional depth perception
of VR enables better visualization and thus assessment of the utero-
placental vascularization. Also, 3D interaction makes accurate
volumetric measurements feasible. To enable future clinical
implementation of VR, a VR desktop system, using the same V-
Scope software, was developed and validated by using the I-Space
as reference standard [17]. The VR desktop consists of a personal
computer with V-Scope software, a 2D monitor displaying the user
interface for selecting the measurement tools, a 3D monitor to
display the 3D volume, a tracking system for observer interaction
with the 3D volume, a pair of stereoscopic glasses to obtain depth
perception and a six degrees-of-freedom mouse for 3D volume
manipulation as demonstrated in Supplementary Video 1 [17].
Supplementary video related to this article can be found at
https://doi.org/10.1016/j.placenta.2017.11.013.
Detailed measurements in the I-Space and on the VR desktop
were performed by two researchers according to a standard pro-
tocol. Semi-automatic volume measurements of the utero-
placental vasculature were obtained by thresholding the 8-bit
(range 0e255) Doppler magnitude data. As previously published,
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means that only voxels with a Doppler value of 100 or higher are
colored and counted by semi-automatic calculations. This enabled
the most optimal visualization of the utero-placental vasculature
[20,21]. To measure the uterine vasculature in preconceptional ul-
trasound volumes, we used differences in echogenicity of the
uterine and surrounding tissues. Preconceptional uterine vascular
volumes (UVV) were calculated after removing artifacts, recogniz-
able by their stripe-like appearance, with a virtual eraser, i.e.
deselecting voxels that were initially selected by the thresholding
step. In pregnancy, differences in grey values between placental
and myometrial tissue were used to selectively measure placental
vasculature. By removing grey values and vessels up to the
placenta, only placental blood spaces were measured using semi-
automated calculations. The obtained total vascular volume (TVV)
was calculated after removing artifacts. Thereafter, the embryonic
vascular volume (EVV) was identiﬁed and measured by erasing
selected embryonic vascular structures and calculating the differ-
ence with previously obtained TVV. Finally, to select the placental
vascular volume (PVV) only, grey values in the volumewere used to
identify surrounding myometrial tissues. The complete myome-
trium was then erased using the virtual brush to the margin of the
placental tissue interface, leaving the (PVV) (Fig. 1) [20]. At this
stage, it is not possible with VR technology to make a distinction
between the maternal blood space and embryonic vasculature
within the placental vascular volume.
In VR, the quality of both acquired 3D PD ultrasound volumes at
each time point, was scored based on presence of artifacts due to
maternal and/or embryonic movements (yes/no), presence ofFig. 1. Three-dimensional power Doppler ultrasound images of utero-placental vascular volu
a: Slice view of a midsagittal uterine section showing the preconceptional uterine vascular
b: Volume view of ﬁgure 1a showing only the preconceptional uterine vascular volume (U
c: Slice view of a total obtained utero-placental vascular volume in pregnancy, with surrou
d: Volume view of ﬁgure 1c showing the total obtained utero-placental vascular volume in
e: Slice view of a total obtained utero-placental vascular volume in pregnancy, with surrou
vessels (blue); placental vessels (PVV, red); embryonic vessels (EVV, green).
f: Volume view of ﬁgure 1e, showing marked vessel subtypes (UVV (blue); placental vascuacoustic shadowing (yes/no), volume completeness (complete/
incomplete), placental position in relation to the transducer (far/
close) and overall quality (low/average/good). The volume with the
highest score or, in cases of equal scores, the ﬁrst volume was used
for further analysis. Supplementary Fig.1 displays a ﬂowchart of the
ultrasound volume acquisition, the VR measurements and the
comparisons used to assess agreement between two trained ob-
servers (IR and AF) and the two VR systems. For intra- and inter-
observer reliability, each observer measured the highest quality
3D PD ultrasound volume twice on different days in the I-Space.
The same steps were repeated on the VR desktop. The observers
performed their measurements independently, and were blinded
to each other's results.
2.4. Statistical analysis
Because of skewed distributions, vascular volumes were log
transformed prior to analysis. The I-Space system was considered
the reference standard when determining intra-and inter-observer
as well as VR intersystem reproducibility. Scatterplots with corre-
sponding Pearson's correlation coefﬁcients (R-values) were used to
depict correlations between individual measurements for utero-
placental vascular volumes. To quantify intra- and inter-observer
reproducibility, intra-class correlation coefﬁcients (ICC) were
calculated per time point of ultrasound acquisition. Good agree-
ment was deﬁned as an ICC of 0.80 or higher. Of the measurements,
the means of the absolute differences (i.e., the difference between
ﬁrst and secondmeasurement) and the relative differences (i.e., the
difference between natural log values of the ﬁrst and secondmes preconceptional and in pregnancy at 9 weeks GA visualized by Virtual Reality (VR).
volume (UVV, orange), with surrounding grey values representing the uterine tissue.
VV, orange), after setting a threshold for grey values.
nding grey values representing the uterine tissue.
pregnancy, after setting a threshold for grey values.
nding grey values representing the uterine tissue and marked vessel subtypes (uterine
lar volume (PVV, red); embryonic vascular volume (EVV, green)).
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measurements) were calculated with corresponding 95% conﬁ-
dence intervals. Bland-Altman plots were composed to assess
agreement between the two VR systems, displaying mean differ-
ences between utero-placental vascular measurements with cor-
responding 95% limits of agreement. All analyses were performed
using SPSS software (version 21.0; SPSS Inc., Chicago, IL, USA) and p-
values <0.05 were considered statistically signiﬁcant.3. Results
The median age of all women (n ¼ 35) was 33 years (range:
26e41) and median body mass index (BMI) was 23.0 kg/cm2
(range: 19e35). Seventeen women (49%) were nulliparous. All
preconceptional women (n¼5) were undergoing IVF/ICSI treat-
ment. Of the 30 pregnant women, 14 (47%) conceived after IVF/ICSI.
In pregnancy, we observed higher median utero-placental vascular
volumes with advancing GA.
In total, 70 vascular volume measurements were acquired.
Quality was good in 31 volumes, average in 35 volumes and low in 4
volumes. All volumes were eligible for further vascular volume
measurements.
Table 1 provides an overview ofmedian vascular volumes in cm3
and intra- and inter-observer agreement of utero-placental
vascular measurements using the I-space. Preconceptional, intra-
and inter-observer agreement for UVV was excellent with ICC
0.93. In pregnancy, ICC for intra- and inter-observer agreement
for utero-placental vascular volumes ranged from 0.69 to 0.99 for
the entire GA range. Mean relative differences for all utero-
placental vascular volumes were below 20%, except for inter-
observer agreement of PVV at 7 and 11 weeks GA with a relative
mean difference of 20.5% and 50.1%, respectively.
Supplementary table 1 provides an overview of median vascular
volumes and the intra- and inter-observer agreement of utero-
placental vascular measurements using the VR desktop. Intra-
and inter-observer agreement for preconceptional UVV was
excellent with ICC 0.92. In pregnancy, ICC for intra- and inter-
observer agreement for utero-placental vascular volumes ranged
from 0.63 to 0.99 for the entire GA range. Mean relative differences
for all utero-placental vascular volumes were below 20%, except for
inter-observer agreement of EVV at 7 weeks GA of 36.7% and PVV
at 7 and 11 weeks GA with a relative mean difference of 21.5% and
21.4% respectively.
Table 2 shows the agreement of utero-placental vascular mea-
surements between the two VR systems preconceptionally and in
pregnancy. With ICC >0.85, all utero-placental vascular volume
measurements show good to excellent intersystem agreement.Table 1
Measurements and intra- and inter-observer reliability parameters of utero-placental va
Median [range]
(cm3)
Intra-observer variability
ICC Mean difference (cm3)
[þ 95% CI]
Preconception UVV 1.80 [0.97; 5.52] 0.97 0.41 [0.01; 0.84]
(n¼5)
Pregnancy
7 weeks GA PVV 0.37 [0.10; 1.04] 0.97 0.03 [0.01; 0.07]
(n¼10) EVV 0.04 [0.01; 0.18] 0.97 0.00 [0.00; 0.01]
9 weeks GA PVV 4.48 [1.57; 9.16] 0.95 0.23 [0.76; 0.31]
(n¼10) EVV 0.44 [0.23; 0.78] 0.98 0.00 [0.02; 0.03]
11 weeks GA PVV 6.99 [1.90; 16.21] 0.94 1.05 [0.17; 2.26]
(n¼10) EVV 1.34 [0.57; 2.20] 0.90 0.16 [0.05; 0.36]
ICC ¼ intraclass correlation coefﬁcients; CI ¼ conﬁdence interval; GA ¼ gestational age; U
vascular volume.Mean relative differences for all utero-placental vascular volumes
were below 20%.
Supplementary Fig. 2 shows strong correlations (R ¼ 0.89e1.00)
of utero-placental vascular measurements between the two VR
systems. Fig. 2 shows the Bland-Altman plots for relative differ-
ences of utero-placental vascular measurements between the VR
systems, with mean relative differences below 20%.4. Discussion
The data of our pilot study indicate that the utero-placental and
embryonic circulations can be evaluated reliably and accurately
with 3D PD ultrasound and VR techniques. Overall, utero-placental
vascular measurements were feasible and reliable with good to
excellent intra- and inter-observer agreement. Furthermore, there
was excellent VR intersystem agreement with most ICC >0.85 and
relative differences <20% both preconceptionally and throughout
the entire GA range. Only the PVV at 11 weeks GA measured in the
I-Space had a suboptimal inter-observer agreement (ICC 0.69,
relative difference 50.1%). This is probably due to a less clear visu-
alization of the boundary between the placenta and underlying
uterine tissue at that gestational age. It highlights the potential use
of these utero-placental circulation assessment at an early stage of
development.
Previous studies have mainly focused on quantiﬁcation of
placental vascularization by using VOCAL to measure VI, FI and VFI,
with average to good reproducibility [12e14,20,21]. Differences in
machine settings, circumstances for image acquisition (i.e. distance
of utero-placental vessels from the transducer either due to patient
characteristics or mode of image acquisition (transvaginally or
transabdominally)), or relatively small sample sizes could be
related to variations in reproducibility. VOCAL also uses 3D PD ul-
trasound to acquire volumes, but ofﬂine assessment takes place in a
2D setting, instead of a 3D setting, let alone a VR environment.
Some studies have used VOCAL preconceptionally to assess asso-
ciations of (sub)endometrial vascularization with pregnancy rates
after assisted reproduction [7,8]. In pregnancy, this technique has
mainly been used in the late ﬁrst trimester or thereafter [26,27].
Only Ballering et al. have investigated such measurements in the
early ﬁrst trimester in 48 women between 8 and 12 weeks GA and
found that early placental vascular development is different in
nulliparous women from multiparous women [28].
The addition of VR when assessing the uterine, placental and
embryonic vascularization is unique, because it enables evaluation
following ultrasound acquisition and fully beneﬁts the third
dimension resulting in more reliable and detailed quantiﬁcation of
vascular volumes. We already have wide experience in using VR forscular volumes using the I-space Virtual Reality system.
Inter-observer variability
Relative mean
difference (%)
[þ 95% CI]
ICC Mean difference (cm3)
[þ 95% CI]
Relative mean
difference (%)
[þ 95% CI]
14.2 [8.0; 14.2] 0.93 0.27 [0.55; 0.01] 0.27 [0.55; 0.01]
4.0 [7.3; 15.4] 0.88 0.00 [0.16; 0.16] 0.00 [0.16; 0.16]
11.6 [2.0; 25.2] 0.95 0.01 [0.02; 0.00] 0.01 [0.02; 0.00]
3.6 [15.6; 8.5] 0.90 0.62 [0.16; 1.40] 0.62 [0.16; 1.40]
0.8 [5.0; 6.7] 1.00 0.01 [0.00; 0.01] 0.01 [0.00; 0.01]
8.0 [1.3; 18.8] 0.69 2.56 [0.90; 4.21] 2.56 [0.90; 4.21]
8.8 [6.6; 22.6] 0.99 0.00 [0.05; 0.06] 0.00 0.05; 0.06]
VV ¼ uterine vascular volume; PVV ¼ placental vascular volume; EVV ¼ embryonic
Table 2
Inter-system reliability parameters of utero-placental vascular volume measurements using the I-Space and Virtual Reality desktop systems.
ICC Mean difference (cm3)
[þ 95% CI]
Relative mean difference (%)
[þ 95% CI]
Preconception UVV 1.00 0.13 [-0.20; 0.06] 5.5 [6.8; 4.2]
(n¼5)
Pregnancy
7 weeks GA PVV 0.99 0.01 [0.05; 0.02] 0.7 [7.2; 5.8]
(n¼10) EVV 0.98 0.00 [0.01; 0.00] 10.9 [20.1;1.8]
9 weeks GA PVV 0.87 0.00 [0.41; 0.75] 8.5 [9.1; 26.0]
(n¼10) EVV 0.98 0.17 [0.02; 0.02] 0.9 [6.7; 4.9]
11 weeks GA PVV 0.93 1.50 [0.14; 2.87] 16.5 [1.9; 31.1]
(n¼10) EVV 0.97 0.06 [0.02; 0.13] 4.9 [0.4; 10.2]
ICC ¼ intraclass correlation coefﬁcients; CI ¼ conﬁdence interval; GA ¼ gestational age; UVV ¼ uterine vascular volume; PVV ¼ placental vascular volume; EVV ¼ embryonic
vascular volume.
Fig. 2. Bland-Altman plots: relative differences in utero-placental vascular volume measurements between two Virtual Reality systems.
UVV ¼ uterine vascular volume; PVV ¼ placental vascular volume; EVV ¼ embryonic vascular volume; GA ¼ gestational age; Mean ¼ average measurement bias in relative dif-
ferences; 95% LoA ¼ Upper and lower 95% limit of agreement for relative differences (mean difference ±2SD); Log ¼ natural log transformation of utero-placental vascular volumes
to achieve a normal distribution.
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fetal structures [15,16,26,28,29].
An advantage of the VR desktop is that it could potentially be
integrated within existing ultrasound machines for application in
any clinical setting. The system is less expensive and has fewer
logistical constraints, using only a regular personal computer with
V-Scope software, a 3D monitor or television screen and attached
tracking system [17]. These factors facilitate research collaborations
and clinical use of the VR desktop.
To date, imaging methods to assess periconceptional utero-
placental health remain limited. Using 3D PD ultrasound enables
minimally invasive and complete visualization of in vivo human
utero-placental vasculature. Therefore, we hypothesize that utero-
placental vascular volumes can be used as potential markers of
endometrial and placental health and pregnancy outcome.Describing the vasculature by different parameters preconcep-
tionally (UVV) and in pregnancy (PVV and EVV) allows to relate
separate volumes to individual patient characteristics, such as
parity, maternal lifestyle and reproductive complications that affect
endometrial quality, placentation, embryonic health and (adverse)
pregnancy outcome. Ultimately, 3D PD ultrasound measurements
could be part of a move towards more accurate prevention and
treatment strategies starting as early as the periconception period
[12,13].
During the periconception period, ultrasound is a safe method
to assess uterine, embryonic and placental structures. International
guidelines as set for obstetric scanning throughout pregnancy and
the ALARA-principle were followed [23e25]. Further, 3D PD ul-
trasound volume acquisition time was much lower than exposure
time during traditional two-dimensional (2D) scanning and the
I.F. Reijnders et al. / Placenta 61 (2018) 96e102 101embryo only occupied a small segment in the 3D volume, therefore
receiving minimal insonation [30,31].
There are limitations for our study. Firstly, the use of 3D PD
image quality relies on ultrasound settings and is sensitive to ar-
tefacts. To achieve optimal comparability, ultrasound machine
settings were standardized for all patients based on several expert
opinions. It appears that the pulse repetition frequency (PRF) is the
principal factor inﬂuencing 3D PD ultrasound image quality by
affecting detection sensitivity for vascular blood ﬂow. It is therefore
necessary, that the effects of various settings to optimize acquisi-
tion of 3D utero-placental vascular images are evaluated in future
studies. Secondly, even if the impact of maternal movements was
reduced to a minimum during volume acquisition, factors such as
maternal adiposity and artefacts due to embryonic movement or
uterine position (ante- or retroverted) can still interfere with image
quality. In this study, we have not evaluated effects of characteris-
tics such as maternal BMI or parity on image quality, but in none of
the volumes quality was so low that measurements could not be
performed. Thus, a larger study population with longitudinal data
collection is necessary to establish normal distributions for utero-
placental vascularization and associations of these measurements
with maternal characteristics, embryonic growth trajectories and
pregnancy outcome.
In conclusion, preconceptional and ﬁrst trimester utero-
placental vascular volume measurements using 3D PD ultrasound
in the I-Space and VR desktop system are feasible and reliable.
These results support the need for future larger cohort studies to
improve measurement precision. They also support further inves-
tigation of the efﬁcacy of utero-placental vascular measurements
by VR as potential markers for uterine and placental function and
ultimately their use for prediction and prevention of adverse
placenta-related outcomes.
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